Invention Grant
US09587024B2 Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (IGF-1)
有权
用于增强或抑制胰岛素样生长因子1（IGF-1）的单克隆抗体
- Patent Title: Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (IGF-1)
- Patent Title (中): 用于增强或抑制胰岛素样生长因子1（IGF-1）的单克隆抗体
-
Application No.: US14728379Application Date: 2015-06-02
-
Publication No.: US09587024B2Publication Date: 2017-03-07
- Inventor: David Clemmons , Laura Maile , Michael Naso , Francis J. Carr , Timothy D. Jones , Simon William Keen
- Applicant: The University of North Carolina at Chapel Hill
- Applicant Address: US NC Chapel Hill
- Assignee: The University of North Carolina at Chapel Hill
- Current Assignee: The University of North Carolina at Chapel Hill
- Current Assignee Address: US NC Chapel Hill
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: C12N5/00
- IPC: C12N5/00 ; C12N15/00 ; C07H21/04 ; C07K16/28
Abstract:
The present invention provides an antibody or antigen-binding fragment thereof that binds αvβ3 integrin, as well as methods of use in the treatment of diseases and disorders.
Public/Granted literature
- US20150259422A1 Monoclonal Antibodies for Enhancing or Inhibiting Insulin-Like Growth Factor I (IGF-1) Public/Granted day:2015-09-17
Information query
